215164-35-5

Basic information

• Product Name: 4-[3,7,12-Tris-(2-nitro-benzenesulfonyl)-3,7,12,18-tetraaza-bicyclo[12.3.1]octadeca-1⁽¹⁷⁾,14⁽¹⁸⁾,15-trien-16-yl]-piperazine-1-carboxylic acid tert-butyl ester
• CAS NO: 215164-35-5
• Molecular Weight: 988.09
• Mol File: 215164-35-5.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 4-[3,7,12-Tris-(2-nitro-benzenesulfonyl)-3,7,12,18-tetraaza-bicyclo[12.3.1]octadeca-1⁽¹⁷⁾,14⁽¹⁸⁾,15-trien-16-yl]-piperazine-1-carboxylic acid tert-butyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 4-[3,7,12-Tris-(2-nitro-benzenesulfonyl)-3,7,12,18-tetraaza-bicyclo[12.3.1]octadeca-1⁽¹⁷⁾,14⁽¹⁸⁾,15-trien-16-yl]-piperazine-1-carboxylic acid tert-butyl ester(215164-35-5)
• EPA Substance Registry System: 4-[3,7,12-Tris-(2-nitro-benzenesulfonyl)-3,7,12,18-tetraaza-bicyclo[12.3.1]octadeca-1⁽¹⁷⁾,14⁽¹⁸⁾,15-trien-16-yl]-piperazine-1-carboxylic acid tert-butyl ester(215164-35-5)

Safety Data

• Hazardous Substances Data: 215164-35-5(Hazardous Substances Data)

Upstream product

• 215164-32-2 4-[N₄'-(t-Boc)-piperazin-N₁'-yl]pyridine-2,6-dimethanol 
• 215164-31-1 4-piperazinyl-2,6-bis-hydroxymethyl pyridine 
• 24424-99-5 di-tert-butyl dicarbonate 
• 215164-33-3 4-[2,6-Bis-(toluene-4-sulfonyloxymethyl)-pyridin-4-yl]-piperazine-1-carboxylic acid tert-butyl ester 
• 211512-12-8 N¹,N⁴,N⁸-tris(2-nitrobenzenesulfonyl)-1,8-diamino-4-azaoctane 

Downstream Products

• 221298-26-6 16-[N⁴-(1-pyrenebutyryl)piperazin-N¹-yl]-3,7,12-tris(2-nitrobenzenesulfonyl)-3,7,12,18-tetraazabicyclo[12.3.1]octadeca-1⁽¹⁸⁾,14,16-triene 
• 221298-23-3 16-[N⁴-(2-anthraquinonemethyl)piperazin-N¹-yl]-3,7,12-tris(2-nitrobenzenesulfonyl)-3,7,12,18-tetraazabicyclo[12.3.1]octadeca-1⁽¹⁸⁾,14,16-triene 

Relevant articles and documents

New piperazinyl polyazacyclophane scaffolds, libraries and biological activities

Four novel unsymmetric piperazinyl polyazacyclophane scaffolds 1-4 were synthesized in high yields by an efficient cyclization strategy. Twenty-six libraries 12-37 (total 16000 compounds) were generated by a solution-phase combinatorial approach from 1-4 and thirty-eight functional groups. Potent antibacterial and HIV-1 tat/TAR protein-RNA disrupting activities were discovered.